Sage Therapeutics, Inc (SAGE) Dividend History

Company News

• Notice to Long-Term Shareholders of Mercury Systems, Inc. (NASDAQ: MRCY); Methode Electronics, Inc. (NYSE: MEI); Monolithic Power Systems, Inc. (NASDAQ: MPWR); and Sage Therapeutics, Inc. (NASDAQ: SAGE): Grabar Law Office Investigates Claims on Your Behalf

  Grabar Law Office is investigating potential breaches of fiduciary duties by officers and directors at Mercury Systems, Methode Electronics, Monolithic Power Systems, and Sage Therapeutics. The investigations are based on allegations of financial misrepresentations and other misconduct.

  GlobeNewswire Inc.

  Featured Companies: MEI MPWR MRCY
• Long-Term Shareholder Notice: Fluence Energy, Inc. (NASDAQ: FLNC); Kyverna Therapuetics, Inc. (NASDAQ: KYTX); Mercury Systems, Inc. (NASDAQ: MRCY); and Sage Therapeutics, Inc. (NASDAQ: SAGE): Grabar Law Office Investigates Claims on Your Behalf

  Grabar Law Office is investigating claims on behalf of shareholders of Fluence Energy, Kyverna Therapeutics, Mercury Systems, and Sage Therapeutics, alleging breaches of fiduciary duties by certain officers and directors.

  GlobeNewswire Inc.

  Featured Companies: FLNC KYTX MRCY
• Comprehensive Market Analysis of Latest Published Different Types of Depression Reports | DelveInsight

  The depression treatment market is experiencing steady growth, driven by rising mental health awareness, increasing prevalence of depression, and advancements in novel therapies. The market is expanding with the introduction of innovative antidepressants, psychedelic-based treatments, and digital therapeutics.

  GlobeNewswire Inc.

  Featured Companies: ATAI AXSM GHRS JNJ LPCN RLMD
• Deal Dispatch: Sage And Silvus Are Up For Sale, MrBeast Secures $20B For TikTok

  Sage Therapeutics explores strategic options, Biogen submits unsolicited offer; Silvus Technologies considers sale/IPO; Allakos downsizes; MrBeast secures $20B for TikTok bid.

  Benzinga

  Featured Companies: BIIB
• Kuehn Law Encourages Investors of Sage Therapeutics, Inc. to Contact Law Firm

  Kuehn Law is investigating Sage Therapeutics for allegedly misrepresenting the effectiveness of its drug candidates zuranolone, SAGE-718, and SAGE-324, leading to overstated clinical, regulatory, and commercial prospects.

  GlobeNewswire Inc.